6-aryl naphthyridines for inhibiting protein tyrosine kinase mediated
申请人:Warner-Lambert Company
公开号:US05952342A1
公开(公告)日:1999-09-14
6-Aryl naphthyridines are inhibitors of protein tyrosine kinase, and are thus useful in treating cellular proliferation mediated thereby. The compounds are especially useful in treating atherosclerosis, restenosis, psoriasis, as well as bacterial infections.